Sweet syndrome following Moderna COVID-19 vaccine: A case report

With the COVID-19 pandemic, vaccines have been administered all around the world probably more than ever. Even though they are considered safe, with such a huge quantity of doses used, many adverse effects including cutaneous ones were reported. We report here the case of a male adult with a history...

Descripción completa

Detalles Bibliográficos
Autores principales: Pelchat, Frederic, Fournier, Cynthia, Perron, Emilie, Gilbert, Martin, Delisle, Bernard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
JCMS Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382060/
https://www.ncbi.nlm.nih.gov/pubmed/35991953
http://dx.doi.org/10.1177/2050313X221117884
Descripción
Sumario:With the COVID-19 pandemic, vaccines have been administered all around the world probably more than ever. Even though they are considered safe, with such a huge quantity of doses used, many adverse effects including cutaneous ones were reported. We report here the case of a male adult with a history of monoclonal gammopathy of undetermined significance who presented with an extensive cutaneous eruption of indurated erythematous papules and plaques 2 days after receiving his first dose of Moderna COVID-19 vaccine (mRNA-1273 SARS-CoV-2 vaccine). Histopathology was compatible with a histiocytoid Sweet syndrome and history suggested that the vaccine contributed to the eruption.

Ejemplares similares